These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3388433)

  • 1. Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat.
    Smith AC; Roberts SM; Berman LM; Harbison RD; James RC
    Toxicology; 1988 Jun; 50(1):95-105. PubMed ID: 3388433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic differences in reductive metabolism and hepatotoxicity of halothane in three rat strains.
    Gourlay GK; Adams JF; Cousins MJ; Hall P
    Anesthesiology; 1981 Aug; 55(2):96-103. PubMed ID: 7258721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity.
    Smith AC; Berman ML; James RC; Harbison RD
    Biochem Pharmacol; 1983 Dec; 32(23):3531-9. PubMed ID: 6651874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of covalent binding from halothane metabolism in hepatic microsomes from phenobarbital-induced and hyperthyroid rats.
    Smith AC; Roberts SM; James RC; Berman LM; Harbison RD
    Xenobiotica; 1988 Aug; 18(8):991-1001. PubMed ID: 3188577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane hepatotoxicity in hyperthyroid rats as compared to the phenobarbital-hypoxia model.
    Siegers CP; Frühling A; Younes M
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):257-64. PubMed ID: 6868087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model.
    Gourlay GK; Adams JF; Cousins MJ; Sharp JH
    Br J Anaesth; 1980 Mar; 52(3):331-6. PubMed ID: 7370149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the formation of chlorotrifluoroethane and chlorodifluoroethylene from halothane.
    Maiorino RM; Sipes IG; Gandolfi AJ; Brown BR; Lind RC
    Anesthesiology; 1981 May; 54(5):383-9. PubMed ID: 7224207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical effects of perturbation of intracellular levels of glutathione on halothane-induced hepatotoxicity in hyperthyroid rats.
    Smith AC; James RC; Berman ML; Harbison RD
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 1):221-30. PubMed ID: 6724195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoflurane acts as an inhibitor of oxidative dehalogenation while acting as an accelerator of reductive dehalogenation of halothane in guinea pig liver microsomes.
    Fujii K
    Toxicology; 1995 Dec; 104(1-3):123-8. PubMed ID: 8560490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4.
    Kharasch ED; Hankins DC; Fenstamaker K; Cox K
    Eur J Clin Pharmacol; 2000; 55(11-12):853-9. PubMed ID: 10805064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductive halothane metabolite formation and halothane binding in rat hepatic microsomes.
    Baker MT; Van Dyke RA
    Chem Biol Interact; 1984 Apr; 49(1-2):121-32. PubMed ID: 6722932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the reductive metabolism of halothane by microsomal cytochrome b5 in rat liver.
    Tamura S; Kawata S; Sugiyama T; Tarui S
    Biochim Biophys Acta; 1987 Dec; 926(3):231-8. PubMed ID: 3689822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
    Spracklin DK; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory effects of halothane and isoflurane on fluoride release and cytochrome P-450 loss caused by metabolism of 2-chloro-1,1-difluoroethene, a halothane metabolite.
    Baker MT; Bates JN; Leff SV
    Anesth Analg; 1987 Nov; 66(11):1141-7. PubMed ID: 2889401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.
    McLain GE; Sipes IG; Brown BR
    Anesthesiology; 1979 Oct; 51(4):321-6. PubMed ID: 484893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats.
    Dalvi RR; Dalvi PS
    Drug Chem Toxicol; 1991; 14(1-2):219-29. PubMed ID: 1889377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halothane hepatotoxicity and the reduced derivative, 1,1,1-trifluoro-2-chloroethane.
    Brown BR; Sipes IG; Baker RK
    Environ Health Perspect; 1977 Dec; 21():185-8. PubMed ID: 612444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cimetidine and ranitidine on halothane metabolism and hepatotoxicity in an animal model.
    Plummer JL; Wanwimolruk S; Jenner MA; Hall PD; Cousins MJ
    Drug Metab Dispos; 1984; 12(1):106-10. PubMed ID: 6141900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane hepatotoxicity in glutathione depleted rats.
    Wilhelm KP; Younes M; Sellin D; Siegers CP
    J Appl Toxicol; 1987 Apr; 7(2):105-10. PubMed ID: 3624765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modulation of 1,2-dibromo-3-chloropropane toxicity.
    Kluwe WM
    Toxicology; 1983; 27(3-4):287-99. PubMed ID: 6623477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.